UWM
LUMO

Urban Wealth Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Urban Wealth Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$27K Buy
+3,490
New +$27.9K 0.09% 128

Other funds holding LUMO

Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Urban Wealth Management's LUMO Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2022: 3,490 shares worth $27K. The stake represents 0.09% of the portfolio and ranks #128 among its holdings.

36 funds tracked by Wall St. Rank hold LUMO as of Q2 2022.

  • Urban Wealth Management held 3,490 shares of Lumos Pharma, Inc. Common Stock worth $27K as of Q2 2022.
  • Lumos Pharma, Inc. Common Stock was a new Urban Wealth Management position in Q2 2022.
  • Lumos Pharma, Inc. Common Stock made up 0.09% of Urban Wealth Management's portfolio in Q2 2022, its #128 holding.
  • 36 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.